The 36-month beta value for NDRA is also noteworthy at 1.01. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for NDRA is 10.88M, and at present, short sellers hold a 0.45% of that float. The average trading volume of NDRA on April 01, 2024 was 132.17K shares.
NDRA) stock’s latest price update
The stock price of ENDRA Life Sciences Inc (NASDAQ: NDRA) has dropped by -29.29 compared to previous close of 0.82. Despite this, the company has seen a fall of -38.28% in its stock price over the last five trading days. Seeking Alpha reported 2024-03-28 that ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript
NDRA’s Market Performance
ENDRA Life Sciences Inc (NDRA) has seen a -38.28% fall in stock performance for the week, with a -48.21% decline in the past month and a -70.71% plunge in the past quarter. The volatility ratio for the week is 19.19%, and the volatility levels for the past 30 days are at 11.23% for NDRA. The simple moving average for the past 20 days is -44.91% for NDRA’s stock, with a -51.86% simple moving average for the past 200 days.
NDRA Trading at -46.24% from the 50-Day Moving Average
After a stumble in the market that brought NDRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.07% of loss for the given period.
Volatility was left at 11.23%, however, over the last 30 days, the volatility rate increased by 19.19%, as shares sank -48.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -52.46% lower at present.
During the last 5 trading sessions, NDRA fell by -38.28%, which changed the moving average for the period of 200-days by -60.81% in comparison to the 20-day moving average, which settled at $1.0258. In addition, ENDRA Life Sciences Inc saw -72.64% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NDRA starting from Thornton Michael Milos, who purchase 15,000 shares at the price of $1.65 back on May 18 ’23. After this action, Thornton Michael Milos now owns 34,139 shares of ENDRA Life Sciences Inc, valued at $24,750 using the latest closing price.
DIGIANDOMENICO ANTHONY, the Director of ENDRA Life Sciences Inc, purchase 83,333 shares at $1.20 during a trade that took place back on May 02 ’23, which means that DIGIANDOMENICO ANTHONY is holding 102,434 shares at $100,000 based on the most recent closing price.
Stock Fundamentals for NDRA
The total capital return value is set at -1.8. Equity return is now at value -156.42, with -125.53 for asset returns.
Based on ENDRA Life Sciences Inc (NDRA), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at -16.28. The debt to equity ratio resting at 0.1. The interest coverage ratio of the stock is -3078.04.
Currently, EBITDA for the company is -10.25 million with net debt to EBITDA at 0.24. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.36.
Conclusion
In summary, ENDRA Life Sciences Inc (NDRA) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
